Nat Genet:新基因HMGA2关联大脑尺寸及智力

2012-04-20 mumu 生物谷

在全世界最大规模的脑研究中,由来自全世界100个研究机构的200多个研究人员组成的研究小组,共同绘制出一些人类基因,这些基因有的促进大脑抵抗各种精神疾病与阿尔茨海默病,有的破坏大脑对那些疾病的抵抗。相关研究结果发表在4月15日在线版Nature Genetics上,揭示了用来解释大脑大小与智力个体差异的新基因。 研究人员不仅探讨增加单一疾病遗传风险的基因,也对导致组织萎缩和大脑尺寸减小的因素进行

在全世界最大规模的脑研究中,由来自全世界100个研究机构的200多个研究人员组成的研究小组,共同绘制出一些人类基因,这些基因有的促进大脑抵抗各种精神疾病与阿尔茨海默病,有的破坏大脑对那些疾病的抵抗。相关研究结果发表在4月15日在线版Nature Genetics上,揭示了用来解释大脑大小与智力个体差异的新基因。

研究人员不仅探讨增加单一疾病遗传风险的基因,也对导致组织萎缩和大脑尺寸减小的因素进行了研究,也就是遗传性疾病生物学标志,这里的遗传性疾病主要是精神分裂症、双相性精神障碍、抑郁症、阿尔茨海默症和痴呆。同时,还特别地寻找出使健康人脑组织超常耗竭的基因变异。此项目规模庞大,足以使研究小组发掘某些人的新遗传变异,这些人不但有更大体积的大脑,而且学习记忆关键域存在差异。结果发现,有一种统一联系,该联系存在遗传密码细微变化与记忆中心缩减之间,即:HMGA2基因的一个变异既影响大脑尺寸,也影响智力。若某人HMGA2基因上T碱基被C碱基替代,他就会有一个尺寸较大的大脑,在标准IQ测试中得分也高得多。

此研究提供了相当明确的证据,来证明大脑功能、智力与遗传的关联。因为,像阿尔茨海默症、孤独症及精神分裂症这样的疾病能瓦解大脑“电路系统”,所以,下一步将要搜寻出那些影响大脑连线的基因。

doi:10.1038/ng.2250
PMC:
PMID:

Identification of common variants associated with human hippocampal and intracranial volumes

Jason L Stein, Sarah E Medland, Alejandro Arias Vasquez, Derrek P Hibar, Rudy E Senstad,Anderson M Winkler, Roberto Toro, Katja Appel, Richard Bartecek, ?rjan Bergmann, Manon Bernard, Andrew A Brown, Dara M Cannon, M Mallar Chakravarty, Andrea Christoforou, Martin Domin, Oliver Grimm, Marisa Hollinshead, Avram J Holmes, Georg Homuth, Jouke-Jan Hottenga,Camilla Langan, Lorna M Lopez, Narelle K Hansell, Kristy S Hwang et al.

Identifying genetic variants influencing human brain structures may reveal new biological mechanisms underlying cognition and neuropsychiatric illness. The volume of the hippocampus is a biomarker of incipient Alzheimer's disease1, 2 and is reduced in schizophrenia3, major depression4 and mesial temporal lobe epilepsy5. Whereas many brain imaging phenotypes are highly heritable6, 7, identifying and replicating genetic influences has been difficult, as small effects and the high costs of magnetic resonance imaging (MRI) have led to underpowered studies. Here we report genome-wide association meta-analyses and replication for mean bilateral hippocampal, total brain and intracranial volumes from a large multinational consortium. The intergenic variant rs7294919 was associated with hippocampal volume (12q24.22; N = 21,151; P = 6.70 × 10-16) and the expression levels of the positional candidate gene TESC in brain tissue. Additionally, rs10784502, located within HMGA2, was associated with intracranial volume (12q14.3; N = 15,782; P = 1.12 × 10-12). We also identified a suggestive association with total brain volume at rs10494373 within DDR2 (1q23.3; N = 6,500; P = 5.81 × 10-7).

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1733592, encodeId=32dd1e33592d4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 20 08:14:00 CST 2013, time=2013-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879212, encodeId=761218e9212c1, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Feb 11 20:14:00 CST 2013, time=2013-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048433, encodeId=c8f92048433ea, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Aug 02 15:14:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685853, encodeId=615316858537b, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sun Sep 16 07:14:00 CST 2012, time=2012-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616343, encodeId=278916163432a, content=<a href='/topic/show?id=0d9658313ea' target=_blank style='color:#2F92EE;'>#新基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58313, encryptionId=0d9658313ea, topicName=新基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd7919746090, createdName=12498b3em14(暂无昵称), createdTime=Sun Apr 22 10:14:00 CST 2012, time=2012-04-22, status=1, ipAttribution=)]
    2013-02-20 canlab
  2. [GetPortalCommentsPageByObjectIdResponse(id=1733592, encodeId=32dd1e33592d4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 20 08:14:00 CST 2013, time=2013-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879212, encodeId=761218e9212c1, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Feb 11 20:14:00 CST 2013, time=2013-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048433, encodeId=c8f92048433ea, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Aug 02 15:14:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685853, encodeId=615316858537b, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sun Sep 16 07:14:00 CST 2012, time=2012-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616343, encodeId=278916163432a, content=<a href='/topic/show?id=0d9658313ea' target=_blank style='color:#2F92EE;'>#新基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58313, encryptionId=0d9658313ea, topicName=新基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd7919746090, createdName=12498b3em14(暂无昵称), createdTime=Sun Apr 22 10:14:00 CST 2012, time=2012-04-22, status=1, ipAttribution=)]
    2013-02-11 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=1733592, encodeId=32dd1e33592d4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 20 08:14:00 CST 2013, time=2013-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879212, encodeId=761218e9212c1, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Feb 11 20:14:00 CST 2013, time=2013-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048433, encodeId=c8f92048433ea, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Aug 02 15:14:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685853, encodeId=615316858537b, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sun Sep 16 07:14:00 CST 2012, time=2012-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616343, encodeId=278916163432a, content=<a href='/topic/show?id=0d9658313ea' target=_blank style='color:#2F92EE;'>#新基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58313, encryptionId=0d9658313ea, topicName=新基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd7919746090, createdName=12498b3em14(暂无昵称), createdTime=Sun Apr 22 10:14:00 CST 2012, time=2012-04-22, status=1, ipAttribution=)]
    2012-08-02 cy0324
  4. [GetPortalCommentsPageByObjectIdResponse(id=1733592, encodeId=32dd1e33592d4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 20 08:14:00 CST 2013, time=2013-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879212, encodeId=761218e9212c1, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Feb 11 20:14:00 CST 2013, time=2013-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048433, encodeId=c8f92048433ea, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Aug 02 15:14:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685853, encodeId=615316858537b, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sun Sep 16 07:14:00 CST 2012, time=2012-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616343, encodeId=278916163432a, content=<a href='/topic/show?id=0d9658313ea' target=_blank style='color:#2F92EE;'>#新基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58313, encryptionId=0d9658313ea, topicName=新基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd7919746090, createdName=12498b3em14(暂无昵称), createdTime=Sun Apr 22 10:14:00 CST 2012, time=2012-04-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1733592, encodeId=32dd1e33592d4, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 20 08:14:00 CST 2013, time=2013-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879212, encodeId=761218e9212c1, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Feb 11 20:14:00 CST 2013, time=2013-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048433, encodeId=c8f92048433ea, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Aug 02 15:14:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685853, encodeId=615316858537b, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sun Sep 16 07:14:00 CST 2012, time=2012-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616343, encodeId=278916163432a, content=<a href='/topic/show?id=0d9658313ea' target=_blank style='color:#2F92EE;'>#新基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58313, encryptionId=0d9658313ea, topicName=新基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd7919746090, createdName=12498b3em14(暂无昵称), createdTime=Sun Apr 22 10:14:00 CST 2012, time=2012-04-22, status=1, ipAttribution=)]

相关资讯

Nature:基因ZfP521在脑神经形成过程中发挥决定性作用

日本一个研究小组日前报告说,他们发现了在脑神经形成过程中发挥决定性作用的基因,这一发现将有助于提高再生医疗的安全性和效果。 利用胚胎干细胞和诱导多功能干细胞(iPS细胞)等培育脑神经细胞以用于再生医疗移植时,往往还会形成其他细胞,因此需要把生成的神经细胞和其他细胞区分开来。为解决上述问题,研究人员一直希望弄清脑神经细胞的形成机制。 日本理化学研究所的一个研究小组在新一期英国《自然》杂志网络版上

PLoS ONE:欧洲科学家首次发现提高大脑认知功能的机理

欧盟第七研发框架计划(FP7)资助290万欧元,由丹麦、西班牙和瑞士科学家组成的研究团队,在分子和细胞学研究方面取得重要进展,首次发现提高大脑认知功能的机理。该发现对治疗老年痴呆症、孤独症和各种精神失调疾病具有潜力,研究结果在最新一期的《公共科学图书馆生物学》PLoS Biology杂志上发表。 大脑中连接神经元的突融,对人类的认知功能起着举足轻重的关键作用,尤其是控制大脑认知功能活力的突融模式

单纤维肌电图可判断糖尿病周围神经病变预后

  最近,东南大学医学院附属江阴医院的研究人员的一项研究显示,单纤维肌电图(SFEMG)对糖尿病周围神经病变(DPN)的诊断意义显著,并且可用于DPN的预后判断。该研究发表于2012年第1期《临床神经病学杂志》。    更多还原该研究旨在探讨SFEMG对DPN的应用价值。   陆强彬等研究人员应用SFEMG检测129例DPN患者的优势侧指总伸肌颤抖(jitter)和纤维密度(FD),